Sarepta Therapeutics Inc. (SRPT) NASDAQ
$128.38 -0.73 (-0.56%)
Market Cap: $11.36B
As of 03/23/23 04:00 PM EDT. Market closed.
Sarepta Therapeutics Inc. (SRPT)
NASDAQ
$128.38
-0.73 (-0.56%)
Market Cap: $11.36B
As of 03/23/23 04:00 PM EDT. Market closed.
Sarepta Therapeutics Inc. is leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people living with raredisease. The Company has built an impressive position in Duchenne muscular dystrophy (DMD) and in gene therapies for limb-girdle muscular dystrophies (LGMDs), mucopolysaccharidosis type IIIA, Charcot-Marie-Tooth (CMT), and other CNS-related ... read more
Sarepta Therapeutics Inc. is leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people living with raredisease. The Company has built an impressive position in Duchenne muscular dystrophy (DMD) and in gene therapies for limb-girdle muscular dystrophies (LGMDs), mucopolysaccharidosis type IIIA, Charcot-Marie-Tooth (CMT), and other CNS-related disorders, with more than 40 programs in various stages of development. The Company's programs and research focus span several therapeutic modalities, including RNA, gene therapy and gene editing. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Douglas Ingram
Full Time Employees
840
CEO Compensation (Base)
$650,000
CEO Compensation (Total)
$1.43M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Douglas Ingram
Full Time Employees
840
CEO Compensation (Base)
$650,000
CEO Compensation (Total)
$1.43M
Address
215 1st St Ste 415, Massachusetts, Cambridge, 02142-1213.
PRICE CHART FOR SAREPTA THERAPEUTICS INC
From:
To:
NEWS
KEY STATS
Open
$130.87
Previous Close
$129.11
Days Range
$125.67 - $131.12
52 week range
$61.28 - $159.84
Volume
991,267
Avg. Volume (30 days)
2,248,270
Market Cap
$11.36B
Dividend Yield
0.00%
P/E
-16.15
Shares Outstanding
87,981,885
Open
$130.87
Previous Close
$129.11
Days Range
$125.67 - $131.12
52 week range
$61.28 - $159.84
Volume
991,267
Avg. Volume (30 days)
2,248,270
Market Cap
$11.36B
Dividend Yield
0.00%
P/E
-16.15
Shares Outstanding
87,981,885
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SAREPTA THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Rodino-Klapac Louise | Head of R&D, CSO | Mar 08, 2023 | Option Exercise | $153.19 | 912 | 139,709 | 70,170 | Mar 10, 2023, 08:00 PM |
| Estepan Ian Michael | Chief Financial Officer | Mar 08, 2023 | Option Exercise | $153.19 | 744 | 113,973 | 34,679 | Mar 10, 2023, 08:00 PM |
| Brown Ryan Edward | SVP, General Counsel | Mar 08, 2023 | Option Exercise | $153.19 | 635 | 97,276 | 28,185 | Mar 10, 2023, 08:00 PM |
| Arif Bilal | Chief Tech Ops Officer | Mar 08, 2023 | Option Exercise | $153.19 | 314 | 48,102 | 26,674 | Mar 10, 2023, 08:00 PM |
| Arif Bilal | Chief Tech Ops Officer | Mar 06, 2023 | Option Exercise | $157.21 | 340 | 53,451 | 22,642 | Mar 08, 2023, 08:00 PM |
| Estepan Ian Michael | Chief Financial Officer | Mar 06, 2023 | Option Exercise | $157.21 | 1,370 | 215,378 | 30,923 | Mar 08, 2023, 08:00 PM |
| Rodino-Klapac Louise | Head of R&D, CSO | Mar 06, 2023 | Option Exercise | $157.21 | 1,134 | 178,276 | 66,582 | Mar 08, 2023, 08:00 PM |
| Brown Ryan Edward | SVP, General Counsel | Mar 06, 2023 | Option Exercise | $157.21 | 1,325 | 208,303 | 24,491 | Mar 08, 2023, 08:00 PM |
| Arif Bilal | Chief Tech Ops Officer | Mar 01, 2023 | Option Exercise | $147.57 | 252 | 37,188 | 22,837 | Mar 03, 2023, 08:01 PM |
| Brown Ryan Edward | SVP, General Counsel | Mar 01, 2023 | Option Exercise | $147.57 | 196 | 28,924 | 25,645 | Mar 03, 2023, 08:01 PM |
| Estepan Ian Michael | Chief Financial Officer | Mar 01, 2023 | Option Exercise | $147.57 | 378 | 55,781 | 32,293 | Mar 03, 2023, 08:00 PM |
| Rodino-Klapac Louise | Head of R&D, CSO | Mar 01, 2023 | Option Exercise | $147.57 | 522 | 77,032 | 67,716 | Mar 03, 2023, 08:00 PM |
| BEHRENS M KATHLEEN | Director | Dec 19, 2022 | Option Exercise | $34.92 | 20,000 | 698,400 | 158,470 | Dec 21, 2022, 09:05 AM |
| Rodino-Klapac Louise | Head of R&D, CSO | Nov 17, 2022 | Option Exercise | $108.52 | 4,211 | 456,978 | 67,998 | Nov 21, 2022, 08:02 PM |
| Mayo Stephen | Director | Nov 17, 2022 | Sale | $109.92 | 858 | 94,311 | 6,387 | Nov 21, 2022, 08:00 PM |
| Chambers Michael Andrew | Director | Sep 14, 2022 | Buy | $104.43 | 57,100 | 5,963,124 | 108,178 | Sep 15, 2022, 08:00 AM |
| Chambers Michael Andrew | Director | Aug 19, 2022 | Buy | $108.28 | 46,170 | 4,999,230 | 51,078 | Aug 22, 2022, 08:30 AM |
| Brown Ryan Edward | SVP, General Counsel | Jun 01, 2022 | Option Exercise | $72.67 | 54 | 3,924 | 25,841 | Jun 03, 2022, 08:00 PM |
| Estepan Ian Michael | Chief Financial Officer | Mar 07, 2022 | Option Exercise | $79.36 | 398 | 31,585 | 24,671 | Mar 08, 2022, 08:02 PM |
| Estepan Ian Michael | Chief Financial Officer | Mar 04, 2022 | Option Exercise | $79.20 | 1,308 | 103,594 | 25,069 | Mar 08, 2022, 08:02 PM |
| Brown Ryan Edward | SVP, General Counsel | Mar 07, 2022 | Option Exercise | $79.36 | 153 | 12,142 | 17,895 | Mar 08, 2022, 08:02 PM |
| Brown Ryan Edward | SVP, General Counsel | Mar 04, 2022 | Option Exercise | $79.20 | 1,136 | 89,971 | 18,048 | Mar 08, 2022, 08:02 PM |
| Ciambrone William | EVP | Mar 04, 2022 | Option Exercise | $79.20 | 1,160 | 91,872 | 14,099 | Mar 08, 2022, 08:01 PM |
| Rodino-Klapac Louise | Head of R&D, CSO | Mar 04, 2022 | Option Exercise | $79.20 | 1,216 | 96,307 | 64,111 | Mar 08, 2022, 08:00 PM |
| Rodino-Klapac Louise | Head of R&D, CSO | Mar 01, 2022 | Option Exercise | $75.05 | 572 | 42,929 | 65,327 | Mar 01, 2022, 08:03 PM |
| Estepan Ian Michael | Chief Financial Officer | Mar 01, 2022 | Option Exercise | $75.05 | 376 | 28,219 | 26,377 | Mar 01, 2022, 08:02 PM |
| Brown Ryan Edward | SVP, General Counsel | Mar 01, 2022 | Option Exercise | $75.05 | 184 | 13,809 | 19,184 | Mar 01, 2022, 08:01 PM |
| BEHRENS M KATHLEEN | Director | Dec 15, 2021 | Option Exercise | $10.08 | 5,000 | 50,400 | 135,517 | Dec 16, 2021, 08:00 PM |
| Rodino-Klapac Louise | Head of R&D, CSO | Nov 24, 2021 | Buy | $79.33 | 3,780 | 299,867 | 65,678 | Nov 29, 2021, 08:00 AM |
| INGRAM DOUGLAS S | President & CEO | Nov 17, 2021 | Buy | $79.94 | 25,026 | 2,000,579 | 365,082 | Nov 17, 2021, 06:24 PM |
| Estepan Ian Michael | Chief Financial Officer | Sep 08, 2021 | Option Exercise | $78.29 | 1,623 | 127,065 | 26,753 | Sep 09, 2021, 08:00 PM |
| INGRAM DOUGLAS S | President & CEO | Jun 26, 2021 | Option Exercise | $80.40 | 17,812 | 1,432,085 | 340,056 | Jun 28, 2021, 08:00 PM |
| BEHRENS M KATHLEEN | Director | Mar 10, 2021 | Option Exercise | $42.30 | 5,000 | 211,500 | 135,517 | Mar 10, 2021, 08:04 PM |
| BEHRENS M KATHLEEN | Director | Mar 10, 2021 | Sale | $85.76 | 5,000 | 428,800 | 130,517 | Mar 10, 2021, 08:04 PM |
| Wigzell Hans Lennart Rudolf | Director | Mar 08, 2021 | Option Exercise | $34.92 | 10,000 | 349,200 | 26,518 | Mar 10, 2021, 08:03 PM |
| Wigzell Hans Lennart Rudolf | Director | Mar 08, 2021 | Sale | $83.51 | 10,000 | 835,100 | 16,518 | Mar 10, 2021, 08:03 PM |
| O'Neill Gilmore Neil | EVP, R&D & CMO | Feb 28, 2021 | Option Exercise | $86.97 | 524 | 45,572 | 13,546 | Mar 10, 2021, 08:02 PM |
| Brown Ryan Edward | SVP, General Counsel | Feb 28, 2021 | Option Exercise | $86.97 | 216 | 18,786 | 4,622 | Mar 10, 2021, 08:01 PM |
| Brown Ryan Edward | SVP, General Counsel | Mar 04, 2021 | Option Exercise | $80.76 | 190 | 15,344 | 19,432 | Mar 10, 2021, 08:01 PM |
| Rodino-Klapac Louise | Chief Scientific Officer | Feb 28, 2021 | Option Exercise | $86.97 | 565 | 49,138 | 6,604 | Mar 10, 2021, 08:01 PM |
| Estepan Ian Michael | Chief Financial Officer | Mar 05, 2021 | Option Exercise | $84.65 | 347 | 29,374 | 28,376 | Mar 10, 2021, 08:00 PM |
| Estepan Ian Michael | Chief Financial Officer | Feb 28, 2021 | Option Exercise | $86.97 | 319 | 27,743 | 13,723 | Mar 10, 2021, 08:00 PM |
| INGRAM DOUGLAS S | President & CEO | Dec 31, 2020 | Option Exercise | $170.49 | 37,144 | 6,332,681 | 357,868 | Jan 04, 2021, 08:00 PM |
| Bratica Joseph | Principal Financial Officer | Dec 11, 2020 | Option Exercise | $71.45 | 1,115 | 79,667 | 9,255 | Dec 14, 2020, 08:00 PM |
| Bratica Joseph | Principal Financial Officer | Dec 11, 2020 | Sale | $165.00 | 1,115 | 183,975 | 8,140 | Dec 14, 2020, 08:00 PM |
| Bratica Joseph | Principal Financial Officer | Dec 08, 2020 | Option Exercise | $29.60 | 1,125 | 33,300 | 9,265 | Dec 10, 2020, 08:23 PM |
| Bratica Joseph | Principal Financial Officer | Dec 08, 2020 | Sale | $160.00 | 1,125 | 180,000 | 8,140 | Dec 10, 2020, 08:23 PM |
| Wigzell Hans Lennart Rudolf | Director | Aug 10, 2020 | Option Exercise | $34.92 | 10,000 | 349,200 | 23,792 | Aug 11, 2020, 08:00 PM |
| Wigzell Hans Lennart Rudolf | Director | Aug 10, 2020 | Sale | $159.00 | 10,000 | 1,590,044 | 14,569 | Aug 11, 2020, 08:00 PM |
| Barry Richard | Director | Aug 07, 2020 | Sale | $158.50 | 30,000 | 4,754,972 | 3,132,280 | Aug 07, 2020, 08:00 PM |
| Bratica Joseph | Principal Financial Officer | Aug 03, 2020 | Option Exercise | $29.60 | 1,125 | 33,300 | 8,957 | Aug 05, 2020, 08:00 PM |
| Bratica Joseph | Principal Financial Officer | Aug 03, 2020 | Sale | $155.00 | 1,125 | 174,375 | 7,832 | Aug 05, 2020, 08:00 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Jul 08, 2020 | Option Exercise | $19.69 | 3,806 | 74,941 | 20,260 | Jul 09, 2020, 08:00 PM |
| Howton David T | EVP, General Counsel | Jun 22, 2020 | Option Exercise | $25.76 | 105,122 | 2,708,440 | 136,993 | Jun 22, 2020, 09:17 PM |
| Howton David T | EVP, General Counsel | Jun 22, 2020 | Sale | $170.88 | 105,122 | 17,962,831 | 130,984 | Jun 22, 2020, 09:17 PM |
| Wigzell Hans Lennart Rudolf | Director | May 20, 2020 | Option Exercise | $10.08 | 5,000 | 50,400 | 18,792 | May 22, 2020, 08:00 PM |
| Wigzell Hans Lennart Rudolf | Director | May 20, 2020 | Sale | $150.64 | 5,000 | 753,210 | 16,692 | May 22, 2020, 08:00 PM |
| Barry Richard | Director | May 15, 2020 | Sale | $141.26 | 30,000 | 4,237,946 | 3,163,813 | May 15, 2020, 09:02 PM |
| Wigzell Hans Lennart Rudolf | Director | Mar 04, 2020 | Option Exercise | $8.46 | 5,000 | 42,300 | 18,792 | Mar 06, 2020, 08:01 PM |
| Wigzell Hans Lennart Rudolf | Director | Mar 04, 2020 | Sale | $116.89 | 5,000 | 584,450 | 13,792 | Mar 06, 2020, 08:01 PM |
| INGRAM DOUGLAS S | President & CEO | Dec 31, 2019 | Option Exercise | $129.04 | 37,185 | 4,798,352 | 395,012 | Jan 03, 2020, 08:00 PM |
| Cumbo Alexander | EVP, Chief Commercial Officer | Dec 13, 2019 | Option Exercise | $23.70 | 32,706 | 775,232 | 43,867 | Dec 17, 2019, 08:02 PM |
| Cumbo Alexander | EVP, Chief Commercial Officer | Dec 13, 2019 | Sale | $125.50 | 42,000 | 5,271,000 | 11,161 | Dec 17, 2019, 08:02 PM |
| Howton David T | EVP, General Counsel | Dec 13, 2019 | Option Exercise | $21.48 | 78,000 | 1,675,439 | 103,171 | Dec 17, 2019, 08:01 PM |
| Howton David T | EVP, General Counsel | Dec 13, 2019 | Sale | $125.50 | 78,000 | 9,789,000 | 25,171 | Dec 17, 2019, 08:01 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Dec 13, 2019 | Option Exercise | $28.88 | 125,000 | 3,610,443 | 155,179 | Dec 17, 2019, 08:00 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Dec 13, 2019 | Sale | $125.50 | 125,000 | 15,687,500 | 30,179 | Dec 17, 2019, 08:00 PM |
| Howton David T | EVP, General Counsel | Nov 22, 2019 | Option Exercise | $107.02 | 2,804 | 300,084 | 25,171 | Nov 26, 2019, 08:01 PM |
| Howton David T | EVP, General Counsel | Nov 22, 2019 | Option Exercise | $16.13 | 34,272 | 552,667 | 36,993 | Nov 26, 2019, 08:01 PM |
| Howton David T | EVP, General Counsel | Nov 22, 2019 | Sale | $105.00 | 25,000 | 2,625,000 | 18,703 | Nov 26, 2019, 08:01 PM |
| Barry Richard | Director | Sep 13, 2019 | Buy | $87.49 | 3,309 | 289,504 | 3,187,065 | Sep 16, 2019, 08:00 AM |
| Barry Richard | Director | Sep 12, 2019 | Buy | $87.49 | 1,691 | 147,950 | 3,183,756 | Sep 16, 2019, 08:00 AM |
| BONNEY MICHAEL W | Director | Sep 09, 2019 | Buy | $86.74 | 2,000 | 173,480 | 7,051 | Sep 09, 2019, 02:18 PM |
| BEHRENS M KATHLEEN | Director | Sep 05, 2019 | Option Exercise | $7.80 | 5,000 | 39,000 | 123,167 | Sep 06, 2019, 02:13 PM |
| BEHRENS M KATHLEEN | Director | Sep 06, 2019 | Buy | $87.98 | 2,500 | 219,950 | 125,667 | Sep 06, 2019, 02:13 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Aug 21, 2019 | Option Exercise | $101.50 | 57,465 | 5,832,698 | 72,714 | Aug 22, 2019, 07:20 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Aug 21, 2019 | Option Exercise | $23.85 | 100,000 | 2,385,000 | 130,179 | Aug 22, 2019, 07:20 PM |
| Barry Richard | Director | Aug 20, 2019 | Buy | $99.32 | 5,000 | 496,592 | 3,182,065 | Aug 20, 2019, 05:43 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Aug 15, 2019 | Option Exercise | $24.73 | 9,754 | 241,232 | 30,179 | Aug 15, 2019, 04:33 PM |
| Barry Richard | Director | Aug 14, 2019 | Buy | $122.50 | 3,700 | 453,250 | 3,177,065 | Aug 14, 2019, 04:38 PM |
| Barry Richard | Director | Aug 12, 2019 | Buy | $122.50 | 1,300 | 159,250 | 3,173,365 | Aug 13, 2019, 04:31 PM |
| INGRAM DOUGLAS S | President & CEO | Aug 12, 2019 | Buy | $123.07 | 16,252 | 2,000,160 | 432,197 | Aug 12, 2019, 05:48 PM |
| O'Neill Gilmore Neil | EVP, R&D & CMO | May 24, 2019 | Option Exercise | $119.31 | 4,630 | 552,405 | 7,370 | May 24, 2019, 08:07 PM |
| Wigzell Hans Lennart Rudolf | Director | May 23, 2019 | Option Exercise | $7.80 | 10,000 | 78,000 | 21,717 | May 24, 2019, 08:03 PM |
| Wigzell Hans Lennart Rudolf | Director | May 23, 2019 | Sale | $120.00 | 10,000 | 1,200,000 | 11,717 | May 24, 2019, 08:03 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Mar 28, 2019 | Option Exercise | $118.68 | 2,953 | 350,462 | 20,425 | Mar 29, 2019, 08:01 PM |
| Howton David T | EVP, General Counsel | Mar 28, 2019 | Option Exercise | $118.68 | 2,362 | 280,322 | 18,703 | Mar 29, 2019, 08:00 PM |
| Cumbo Alexander | EVP, Chief Commercial Officer | Mar 28, 2019 | Option Exercise | $118.68 | 2,165 | 256,942 | 11,161 | Mar 29, 2019, 07:59 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Mar 19, 2019 | Option Exercise | $126.47 | 2,625 | 331,984 | 16,729 | Mar 20, 2019, 08:00 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Mar 19, 2019 | Option Exercise | $21.46 | 15,486 | 332,308 | 19,354 | Mar 20, 2019, 08:00 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Feb 07, 2019 | Option Exercise | $23.85 | 65,000 | 1,550,250 | 73,649 | Feb 08, 2019, 08:02 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Feb 07, 2019 | Sale | $145.00 | 65,000 | 9,425,000 | 8,649 | Feb 08, 2019, 08:02 PM |
| Cumbo Alexander | SVP, Chief Commercial Officer | Feb 01, 2019 | Option Exercise | $22.54 | 7,500 | 169,035 | 30,266 | Feb 01, 2019, 08:27 PM |
| Cumbo Alexander | SVP, Chief Commercial Officer | Feb 01, 2019 | Sale | $140.00 | 15,000 | 2,100,000 | 15,266 | Feb 01, 2019, 08:27 PM |
| Howton David T | SVP, General Counsel | Feb 01, 2019 | Option Exercise | $21.65 | 21,500 | 465,391 | 49,571 | Feb 01, 2019, 08:25 PM |
| Howton David T | SVP, General Counsel | Feb 01, 2019 | Sale | $140.00 | 30,000 | 4,200,000 | 19,571 | Feb 01, 2019, 08:25 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Jan 30, 2019 | Option Exercise | $18.27 | 43,802 | 800,077 | 52,451 | Feb 01, 2019, 08:24 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Jan 31, 2019 | Option Exercise | $23.85 | 21,198 | 505,572 | 29,847 | Feb 01, 2019, 08:24 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Jan 30, 2019 | Sale | $130.00 | 43,802 | 5,694,260 | 8,649 | Feb 01, 2019, 08:24 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Jan 31, 2019 | Sale | $130.72 | 21,198 | 2,771,003 | 8,649 | Feb 01, 2019, 08:24 PM |
| Wigzell Hans Lennart Rudolf | Director | Nov 01, 2018 | Option Exercise | $8.94 | 6,667 | 59,603 | 16,751 | Nov 02, 2018, 06:01 PM |
| Wigzell Hans Lennart Rudolf | Director | Nov 01, 2018 | Sale | $140.50 | 6,667 | 936,714 | 10,084 | Nov 02, 2018, 06:01 PM |
| BEHRENS M KATHLEEN | Director | Oct 31, 2018 | Option Exercise | $3.96 | 10,000 | 39,600 | 126,534 | Nov 02, 2018, 06:00 PM |
| BEHRENS M KATHLEEN | Director | Oct 31, 2018 | Sale | $131.71 | 10,000 | 1,317,100 | 116,534 | Nov 02, 2018, 06:00 PM |
| INGRAM DOUGLAS S | President & CEO | Oct 30, 2018 | Buy | $120.39 | 16,695 | 2,009,872 | 415,945 | Oct 30, 2018, 07:05 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Oct 24, 2018 | Option Exercise | $14.88 | 89,400 | 1,330,389 | 128,185 | Oct 26, 2018, 06:43 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Oct 24, 2018 | Sale | $127.74 | 107,524 | 13,735,116 | 20,661 | Oct 26, 2018, 06:43 PM |
| INGRAM DOUGLAS S | President & CEO | Aug 15, 2018 | Buy | $125.26 | 16,000 | 2,004,208 | 399,250 | Aug 16, 2018, 07:30 AM |
| Cumbo Alexander | SVP, Chief Commercial Officer | Aug 08, 2018 | Option Exercise | $121.02 | 6,000 | 726,120 | 22,766 | Aug 08, 2018, 06:16 PM |
| Howton David T | SVP, General Counsel | Aug 08, 2018 | Option Exercise | $121.02 | 6,800 | 822,936 | 28,071 | Aug 08, 2018, 06:14 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Aug 08, 2018 | Option Exercise | $121.02 | 8,501 | 1,028,791 | 38,785 | Aug 08, 2018, 06:14 PM |
| Howton David T | SVP, General Counsel | Jul 16, 2018 | Option Exercise | $13.85 | 50,000 | 692,691 | 72,719 | Jul 17, 2018, 06:01 PM |
| Howton David T | SVP, General Counsel | Jul 16, 2018 | Sale | $136.46 | 50,000 | 6,823,000 | 34,871 | Jul 17, 2018, 06:01 PM |
| Cumbo Alexander | SVP, Chief Commercial Officer | Jul 09, 2018 | Option Exercise | $13.78 | 33,782 | 465,415 | 40,690 | Jul 11, 2018, 06:05 PM |
| Cumbo Alexander | SVP, Chief Commercial Officer | Jul 09, 2018 | Sale | $137.32 | 33,782 | 4,638,944 | 28,766 | Jul 11, 2018, 06:05 PM |
| Barry Richard | Director | Jun 27, 2018 | Sale | $130.34 | 75,000 | 9,775,500 | 3,170,432 | Jun 29, 2018, 06:01 PM |
| INGRAM DOUGLAS S | President & CEO | Jun 26, 2018 | Option Exercise | $135.53 | 36,946 | 5,007,291 | 383,250 | Jun 27, 2018, 05:24 PM |
| Ruff Shamim | SVP, Chief Regulatory Affairs | May 22, 2018 | Option Exercise | $89.22 | 1,305 | 116,432 | 31,936 | May 24, 2018, 06:06 PM |
| Mahatme Sandesh | EVP, CFO & CBO | May 22, 2018 | Option Exercise | $89.22 | 2,024 | 180,581 | 47,286 | May 24, 2018, 06:05 PM |
| Howton David T | SVP, General Counsel | May 22, 2018 | Option Exercise | $89.22 | 1,566 | 139,719 | 34,871 | May 24, 2018, 06:05 PM |
| Cumbo Alexander | SVP, Chief Commercial Officer | May 22, 2018 | Option Exercise | $89.22 | 1,435 | 128,031 | 28,766 | May 24, 2018, 06:04 PM |
| Ruff Shamim | SVP, Chief Regulatory Affairs | Mar 15, 2018 | Option Exercise | $81.22 | 736 | 59,778 | 28,809 | Mar 16, 2018, 06:13 PM |
| Ruff Shamim | SVP, Chief Regulatory Affairs | Mar 15, 2018 | Option Exercise | $23.93 | 2,500 | 59,813 | 29,465 | Mar 16, 2018, 06:13 PM |
| Howton David T | SVP, General Counsel | Mar 15, 2018 | Option Exercise | $81.22 | 680 | 55,230 | 31,118 | Mar 16, 2018, 06:12 PM |
| Howton David T | SVP, General Counsel | Mar 15, 2018 | Option Exercise | $22.15 | 2,500 | 55,382 | 31,727 | Mar 16, 2018, 06:12 PM |
| Cumbo Alexander | SVP, Chief Commercial Officer | Mar 15, 2018 | Option Exercise | $81.22 | 633 | 51,412 | 25,325 | Mar 16, 2018, 06:10 PM |
| Cumbo Alexander | SVP, Chief Commercial Officer | Mar 15, 2018 | Option Exercise | $20.64 | 2,500 | 51,600 | 25,767 | Mar 16, 2018, 06:10 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Mar 15, 2018 | Option Exercise | $81.22 | 734 | 59,615 | 42,661 | Mar 16, 2018, 06:08 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Mar 15, 2018 | Option Exercise | $23.85 | 2,500 | 59,625 | 43,395 | Mar 16, 2018, 06:08 PM |
| Wigzell Hans Lennart Rudolf | Director | Nov 30, 2017 | Option Exercise | $7.38 | 6,667 | 49,202 | 13,333 | Dec 04, 2017, 08:00 PM |
| Wigzell Hans Lennart Rudolf | Director | Nov 30, 2017 | Sale | $55.89 | 6,667 | 372,619 | 6,666 | Dec 04, 2017, 08:00 PM |
| INGRAM DOUGLAS S | President & CEO | Nov 08, 2017 | Buy | $52.44 | 38,138 | 1,999,957 | 420,196 | Nov 13, 2017, 05:00 PM |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | Nov 06, 2017 | Option Exercise | $14.76 | 10,000 | 147,600 | 37,045 | Nov 08, 2017, 08:13 PM |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | Nov 06, 2017 | Sale | $55.00 | 10,000 | 550,000 | 27,045 | Nov 08, 2017, 08:13 PM |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | Oct 03, 2017 | Option Exercise | $14.76 | 11,500 | 169,740 | 38,545 | Oct 05, 2017, 07:24 PM |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | Oct 03, 2017 | Sale | $50.00 | 11,500 | 575,000 | 27,045 | Oct 05, 2017, 07:24 PM |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | Aug 03, 2017 | Option Exercise | $37.88 | 2,882 | 109,170 | 27,045 | Aug 07, 2017, 04:44 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Aug 03, 2017 | Option Exercise | $37.88 | 6,264 | 237,280 | 40,895 | Aug 07, 2017, 04:42 PM |
| Howton David T | SVP, General Counsel | Aug 03, 2017 | Option Exercise | $37.88 | 4,642 | 175,839 | 29,298 | Aug 07, 2017, 04:40 PM |
| Kaye Edward M. MD | Director | Aug 03, 2017 | Option Exercise | $37.88 | 16,703 | 632,710 | 71,229 | Aug 07, 2017, 04:39 PM |
| Cumbo Alexander | SVP, Chief Commercial Officer | Aug 03, 2017 | Option Exercise | $37.88 | 3,169 | 120,042 | 23,458 | Aug 07, 2017, 04:38 PM |
| INGRAM DOUGLAS S | President & CEO | Jul 27, 2017 | Buy | $42.50 | 47,058 | 1,999,965 | 382,058 | Jul 28, 2017, 08:51 AM |
| Mahatme Sandesh | EVP, CFO & CBO | Jul 20, 2017 | Option Exercise | $15.38 | 50,000 | 769,107 | 65,359 | Jul 21, 2017, 09:49 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Jul 21, 2017 | Option Exercise | $23.85 | 1,500 | 35,775 | 33,861 | Jul 21, 2017, 09:49 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Jul 20, 2017 | Sale | $41.00 | 50,000 | 2,050,000 | 32,361 | Jul 21, 2017, 09:49 PM |
| Kaye Edward M. MD | Director | Jul 20, 2017 | Option Exercise | $40.93 | 4,349 | 178,005 | 62,471 | Jul 21, 2017, 09:48 PM |
| Kaye Edward M. MD | Director | Jul 20, 2017 | Sale | $41.00 | 10,000 | 410,000 | 52,471 | Jul 21, 2017, 09:48 PM |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 20, 2017 | Option Exercise | $13.71 | 6,250 | 85,688 | 27,312 | Jul 21, 2017, 09:47 PM |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 21, 2017 | Option Exercise | $14.12 | 5,888 | 83,133 | 25,450 | Jul 21, 2017, 09:47 PM |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 20, 2017 | Sale | $42.00 | 6,250 | 262,500 | 21,062 | Jul 21, 2017, 09:47 PM |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 21, 2017 | Sale | $44.00 | 5,888 | 259,072 | 21,062 | Jul 21, 2017, 09:47 PM |
| Howton David T | SVP, General Counsel | Jul 21, 2017 | Option Exercise | $20.56 | 1,000 | 20,565 | 23,301 | Jul 21, 2017, 09:46 PM |
| Howton David T | SVP, General Counsel | Jul 20, 2017 | Option Exercise | $13.71 | 25,000 | 342,750 | 41,357 | Jul 21, 2017, 09:46 PM |
| Howton David T | SVP, General Counsel | Jul 20, 2017 | Sale | $41.00 | 25,000 | 1,025,000 | 22,301 | Jul 21, 2017, 09:46 PM |
| Cumbo Alexander | SVP, Chief Commercial Officer | Jul 20, 2017 | Option Exercise | $13.71 | 2,500 | 34,275 | 22,793 | Jul 21, 2017, 09:45 PM |
| Cumbo Alexander | SVP, Chief Commercial Officer | Jul 20, 2017 | Sale | $41.00 | 5,918 | 242,638 | 20,293 | Jul 21, 2017, 09:45 PM |
| Kaye Edward M. MD | President & CEO | Apr 20, 2017 | Option Exercise | $32.54 | 4,349 | 141,516 | 66,820 | Apr 24, 2017, 05:11 PM |
| Howton David T | SVP, General Counsel | Mar 19, 2017 | Option Exercise | $30.30 | 152 | 4,606 | 22,301 | Mar 21, 2017, 06:07 PM |
| Mahatme Sandesh | EVP, CFO & CBO | Mar 19, 2017 | Option Exercise | $30.30 | 171 | 5,181 | 32,361 | Mar 21, 2017, 06:05 PM |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | Mar 19, 2017 | Option Exercise | $30.30 | 177 | 5,363 | 21,062 | Mar 21, 2017, 06:01 PM |
| Kaye Edward M. MD | President, CEO & CMO | Jan 20, 2017 | Option Exercise | $32.66 | 4,466 | 145,860 | 71,169 | Jan 24, 2017, 05:52 PM |
| Howton David T | SVP, General Counsel | Nov 09, 2016 | Option Exercise | $23.85 | 1,000 | 23,850 | 22,453 | Nov 10, 2016, 08:27 AM |
| Mahatme Sandesh | Senior Vice President, CFO | Nov 09, 2016 | Option Exercise | $23.85 | 1,000 | 23,850 | 32,532 | Nov 10, 2016, 08:26 AM |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | Nov 08, 2016 | Option Exercise | $26.24 | 1,000 | 26,240 | 21,239 | Nov 10, 2016, 08:20 AM |
| Kaye Edward M. MD | President, CEO & CMO | Nov 09, 2016 | Option Exercise | $8.28 | 3,000 | 24,840 | 75,635 | Nov 10, 2016, 08:19 AM |
| Kaye Edward M. MD | President, CEO & CMO | Oct 20, 2016 | Option Exercise | $49.05 | 4,348 | 213,269 | 72,635 | Oct 24, 2016, 04:33 PM |
| Mahatme Sandesh | Senior Vice President, CFO | Oct 17, 2016 | Option Exercise | $13.90 | 30,000 | 417,000 | 61,532 | Oct 19, 2016, 04:22 PM |
| Mahatme Sandesh | Senior Vice President, CFO | Oct 17, 2016 | Sale | $50.08 | 30,000 | 1,502,502 | 31,532 | Oct 19, 2016, 04:22 PM |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | Sep 22, 2016 | Option Exercise | $13.90 | 7,311 | 101,623 | 27,550 | Sep 30, 2016, 09:58 PM |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | Sep 22, 2016 | Sale | $60.00 | 7,311 | 438,660 | 20,239 | Sep 30, 2016, 09:58 PM |
| Kaye Edward M. MD | President, CEO & CMO | Sep 22, 2016 | Option Exercise | $8.28 | 40,179 | 332,682 | 117,162 | Sep 26, 2016, 04:23 PM |
| Kaye Edward M. MD | President, CEO & CMO | Sep 22, 2016 | Sale | $60.00 | 40,179 | 2,410,740 | 76,983 | Sep 26, 2016, 04:23 PM |
| Howton David T | SVP, General Counsel | Sep 22, 2016 | Option Exercise | $13.90 | 7,000 | 97,300 | 28,453 | Sep 26, 2016, 04:19 PM |
| Howton David T | SVP, General Counsel | Sep 22, 2016 | Sale | $60.00 | 7,000 | 420,000 | 21,453 | Sep 26, 2016, 04:19 PM |
| Aphale Jayant | VP, Technical Operations | Sep 19, 2016 | Option Exercise | $4.62 | 35,000 | 161,700 | 36,490 | Sep 21, 2016, 09:31 PM |
| Aphale Jayant | VP, Technical Operations | Sep 19, 2016 | Sale | $50.00 | 35,000 | 1,750,000 | 11,490 | Sep 21, 2016, 09:31 PM |
| Kaye Edward M. MD | President, CEO & CMO | Sep 19, 2016 | Option Exercise | $6.94 | 24,352 | 168,941 | 89,983 | Sep 21, 2016, 09:29 PM |
| Kaye Edward M. MD | President, CEO & CMO | Sep 19, 2016 | Sale | $50.00 | 24,352 | 1,217,600 | 76,983 | Sep 21, 2016, 09:29 PM |
| Howton David T | SVP, General Counsel | Sep 19, 2016 | Option Exercise | $13.90 | 8,000 | 111,200 | 11,168 | Sep 21, 2016, 09:28 PM |
| Howton David T | SVP, General Counsel | Sep 19, 2016 | Sale | $50.00 | 9,304 | 465,200 | 21,453 | Sep 21, 2016, 09:28 PM |
| Kaye Edward M. MD | SVP Interim CEO & CMO | Sep 14, 2016 | Sale | $30.00 | 24,557 | 736,710 | 76,983 | Sep 16, 2016, 04:04 PM |
| Kaye Edward M. MD | SVP Interim CEO & CMO | Aug 31, 2016 | Option Exercise | $26.07 | 1,487 | 38,766 | 101,540 | Sep 02, 2016, 04:43 PM |
| Mahatme Sandesh | Senior Vice President, CFO | Aug 31, 2016 | Option Exercise | $26.07 | 1,013 | 26,409 | 7,102 | Sep 02, 2016, 04:37 PM |
| Aphale Jayant | SVP, Technical Operations | Aug 31, 2016 | Option Exercise | $26.07 | 765 | 19,944 | 11,490 | Sep 02, 2016, 04:34 PM |
| Howton David T | SVP, General Counsel | Aug 31, 2016 | Option Exercise | $26.07 | 898 | 23,411 | 3,168 | Sep 02, 2016, 04:32 PM |
| Kaye Edward M. MD | SVP Interim CEO & CMO | Jul 20, 2016 | Option Exercise | $22.46 | 3,001 | 67,402 | 103,027 | Jul 22, 2016, 05:20 PM |
| Kaye Edward M. MD | SVP Interim CEO & CMO | Apr 20, 2016 | Option Exercise | $19.71 | 3,001 | 59,150 | 106,028 | Apr 22, 2016, 04:36 PM |
| BEHRENS M KATHLEEN | Director | Mar 16, 2016 | Buy | $14.54 | 10,000 | 145,433 | 21,855 | Mar 16, 2016, 08:15 PM |
| BEHRENS M KATHLEEN | Director | Mar 14, 2016 | Buy | $16.54 | 65,000 | 1,075,275 | 112,166 | Mar 16, 2016, 08:15 PM |
| Barry Richard | Director | Mar 14, 2016 | Buy | $15.66 | 75,000 | 1,174,185 | 3,241,014 | Mar 16, 2016, 08:09 PM |
| Price Ben Gil | Director | Mar 14, 2016 | Buy | $16.70 | 4,500 | 75,144 | 42,830 | Mar 16, 2016, 08:07 PM |
| Kaye Edward M. MD | SVP Interim CEO & CMO | Jan 20, 2016 | Option Exercise | $13.26 | 3,368 | 44,660 | 103,525 | Jan 25, 2016, 01:28 PM |
| Kaye Edward M. MD | SVP Interim CEO & CMO | Oct 20, 2015 | Option Exercise | $26.74 | 3,001 | 80,247 | 106,893 | Oct 22, 2015, 06:24 PM |
| Kaye Edward M. MD | SVP Interim CEO & CMO | Jul 20, 2015 | Option Exercise | $33.48 | 3,000 | 100,440 | 109,094 | Jul 31, 2015, 04:36 PM |
| Kaye Edward M. MD | SVP & Chief Medical Officer | Feb 27, 2015 | Buy | $11.81 | 800 | 9,452 | 1,311 | Mar 03, 2015, 06:48 PM |
| Christopher Nishan Garabedian | President and CEO | Feb 27, 2015 | Buy | $11.81 | 800 | 9,452 | 29,552 | Mar 03, 2015, 06:47 PM |
| CHASE ANTHONY R | Director | Aug 12, 2014 | Option Exercise | $10.68 | 23,450 | 250,446 | 66,194 | Aug 14, 2014, 04:24 PM |
| Aphale Jayant | SVP Technical Operations | Nov 12, 2013 | Sale | $12.56 | 15,933 | 200,134 | 8,500 | Nov 14, 2013, 09:31 PM |
| CHASE ANTHONY R | Director | Nov 14, 2013 | Buy | $13.95 | 10,000 | 139,483 | 41,744 | Nov 14, 2013, 09:30 PM |
| BEHRENS M KATHLEEN | Director | Sep 16, 2013 | Buy | $37.04 | 6,500 | 240,778 | 44,166 | Sep 18, 2013, 09:00 AM |
| HODGMAN JOHN | Director | Sep 03, 2013 | Option Exercise | $17.52 | 5,556 | 97,341 | 9,889 | Sep 05, 2013, 06:26 PM |
| HODGMAN JOHN | Director | Sep 03, 2013 | Sale | $34.97 | 5,556 | 194,316 | 4,333 | Sep 05, 2013, 06:26 PM |
| CHASE ANTHONY R | Director | Aug 22, 2013 | Buy | $32.68 | 3,500 | 114,373 | 31,744 | Aug 23, 2013, 09:01 AM |
| Price Ben Gil | Director | Aug 19, 2013 | Buy | $31.17 | 500 | 15,587 | 35,330 | Aug 20, 2013, 04:08 PM |
| Mahatme Sandesh | Senior Vice President, CFO | Aug 20, 2013 | Buy | $31.10 | 5,000 | 155,500 | 5,000 | Aug 20, 2013, 01:42 PM |
| CHASE ANTHONY R | Director | Jun 14, 2013 | Buy | $38.50 | 10,000 | 385,043 | 28,244 | Jun 18, 2013, 04:51 PM |
| CHASE ANTHONY R | Director | Nov 28, 2012 | Sale | $29.52 | 8,900 | 262,689 | 24,544 | Nov 29, 2012, 01:46 PM |
| CHASE ANTHONY R | Director | Nov 27, 2012 | Sale | $29.04 | 1,100 | 31,940 | 26,144 | Nov 29, 2012, 01:46 PM |
| CHASE ANTHONY R | Director | Nov 14, 2012 | Sale | $25.70 | 10,000 | 257,002 | 28,044 | Nov 15, 2012, 07:12 PM |
| CHASE ANTHONY R | Director | Sep 07, 2012 | Sale | $14.45 | 33,000 | 476,959 | 56,944 | Sep 11, 2012, 05:40 PM |
| BEHRENS M KATHLEEN | Director | Sep 07, 2012 | Buy | $14.73 | 17,500 | 257,724 | 36,666 | Sep 11, 2012, 05:40 PM |
| Price Ben Gil | Director | Mar 14, 2012 | Buy | $1.29 | 30,000 | 38,850 | 197,982 | Mar 15, 2012, 01:37 PM |
| Christopher Nishan Garabedian | President and CEO | Dec 15, 2011 | Buy | $0.58 | 300,000 | 173,640 | 430,000 | Dec 16, 2011, 11:48 AM |
| CHASE ANTHONY R | Director | Sep 13, 2011 | Buy | $1.20 | 20,000 | 24,000 | 416,467 | Sep 14, 2011, 05:45 PM |
| Price Ben Gil | Director | Apr 06, 2011 | Buy | $1.50 | 20,000 | 30,000 | 162,982 | Apr 06, 2011, 05:38 PM |
| Christopher Nishan Garabedian | President and CEO | Apr 06, 2011 | Buy | $1.50 | 130,000 | 195,000 | 130,000 | Apr 06, 2011, 05:37 PM |
| BEHRENS M KATHLEEN | Director | Apr 06, 2011 | Buy | $1.50 | 100,000 | 150,000 | 105,000 | Apr 06, 2011, 05:36 PM |
| BOYLE J DAVID II | CEO | Aug 27, 2010 | Buy | $2.13 | 5,000 | 10,645 | 70,282 | Aug 27, 2010, 06:02 PM |
| Price Ben Gil | Director | Aug 13, 2010 | Buy | $1.93 | 4,000 | 7,720 | 102,982 | Aug 16, 2010, 03:17 PM |
| Hudson Leslie | Former CEO | Jul 30, 2010 | Option Exercise | $1.09 | 183,486 | 200,000 | 568,045 | Aug 02, 2010, 07:28 PM |
| Hudson Leslie | Former CEO | Jul 30, 2010 | Sale | $1.93 | 183,486 | 354,113 | 518,045 | Aug 02, 2010, 07:28 PM |
| Hudson Leslie | Former CEO | Jul 28, 2010 | Option Exercise | $1.09 | 183,486 | 200,000 | 568,045 | Jul 29, 2010, 08:00 PM |
| Hudson Leslie | Former CEO | Jul 28, 2010 | Sale | $1.82 | 183,486 | 334,373 | 498,045 | Jul 29, 2010, 08:00 PM |
| Hudson Leslie | Former CEO | Jul 26, 2010 | Option Exercise | $1.45 | 129,083 | 187,170 | 513,642 | Jul 28, 2010, 12:48 PM |
| Hudson Leslie | Former CEO | Jul 26, 2010 | Sale | $1.90 | 129,083 | 245,897 | 509,559 | Jul 28, 2010, 12:48 PM |
| Hudson Leslie | Former CEO | Jul 23, 2010 | Option Exercise | $1.45 | 205,400 | 297,830 | 589,959 | Jul 26, 2010, 05:37 PM |
| Hudson Leslie | Former CEO | Jul 23, 2010 | Sale | $1.80 | 205,400 | 369,720 | 384,559 | Jul 26, 2010, 05:37 PM |
| Hudson Leslie | Former CEO | Jul 22, 2010 | Option Exercise | $1.45 | 265,517 | 385,000 | 650,076 | Jul 23, 2010, 05:06 PM |
| Hudson Leslie | Former CEO | Jul 22, 2010 | Sale | $1.80 | 265,517 | 477,513 | 596,280 | Jul 23, 2010, 05:06 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Rodino-Klapac Louise | Head of R&D, CSO | 03/08/2023 | 139,709 |
| Estepan Ian Michael | Chief Financial Officer | 03/08/2023 | 113,973 |
| Brown Ryan Edward | SVP, General Counsel | 03/08/2023 | 97,276 |
| Arif Bilal | Chief Tech Ops Officer | 03/08/2023 | 48,102 |
| Arif Bilal | Chief Tech Ops Officer | 03/06/2023 | 53,451 |
| Estepan Ian Michael | Chief Financial Officer | 03/06/2023 | 215,378 |
| Rodino-Klapac Louise | Head of R&D, CSO | 03/06/2023 | 178,276 |
| Brown Ryan Edward | SVP, General Counsel | 03/06/2023 | 208,303 |
| Arif Bilal | Chief Tech Ops Officer | 03/01/2023 | 37,188 |
| Brown Ryan Edward | SVP, General Counsel | 03/01/2023 | 28,924 |
| Estepan Ian Michael | Chief Financial Officer | 03/01/2023 | 55,781 |
| Rodino-Klapac Louise | Head of R&D, CSO | 03/01/2023 | 77,032 |
| BEHRENS M KATHLEEN | Director | 12/19/2022 | 698,400 |
| Rodino-Klapac Louise | Head of R&D, CSO | 11/17/2022 | 456,978 |
| Mayo Stephen | Director | 11/17/2022 | 94,311 |
| Chambers Michael Andrew | Director | 09/14/2022 | 5,963,124 |
| Chambers Michael Andrew | Director | 08/19/2022 | 4,999,230 |
| Brown Ryan Edward | SVP, General Counsel | 06/01/2022 | 3,924 |
| Estepan Ian Michael | Chief Financial Officer | 03/07/2022 | 31,585 |
| Estepan Ian Michael | Chief Financial Officer | 03/04/2022 | 103,594 |
| Brown Ryan Edward | SVP, General Counsel | 03/07/2022 | 12,142 |
| Brown Ryan Edward | SVP, General Counsel | 03/04/2022 | 89,971 |
| Ciambrone William | EVP | 03/04/2022 | 91,872 |
| Rodino-Klapac Louise | Head of R&D, CSO | 03/04/2022 | 96,307 |
| Rodino-Klapac Louise | Head of R&D, CSO | 03/01/2022 | 42,929 |
| Estepan Ian Michael | Chief Financial Officer | 03/01/2022 | 28,219 |
| Brown Ryan Edward | SVP, General Counsel | 03/01/2022 | 13,809 |
| BEHRENS M KATHLEEN | Director | 12/15/2021 | 50,400 |
| Rodino-Klapac Louise | Head of R&D, CSO | 11/24/2021 | 299,867 |
| INGRAM DOUGLAS S | President & CEO | 11/17/2021 | 2,000,579 |
| Estepan Ian Michael | Chief Financial Officer | 09/08/2021 | 127,065 |
| INGRAM DOUGLAS S | President & CEO | 06/26/2021 | 1,432,085 |
| BEHRENS M KATHLEEN | Director | 03/10/2021 | 211,500 |
| BEHRENS M KATHLEEN | Director | 03/10/2021 | 428,800 |
| Wigzell Hans Lennart Rudolf | Director | 03/08/2021 | 349,200 |
| Wigzell Hans Lennart Rudolf | Director | 03/08/2021 | 835,100 |
| O'Neill Gilmore Neil | EVP, R&D & CMO | 02/28/2021 | 45,572 |
| Brown Ryan Edward | SVP, General Counsel | 02/28/2021 | 18,786 |
| Brown Ryan Edward | SVP, General Counsel | 03/04/2021 | 15,344 |
| Rodino-Klapac Louise | Chief Scientific Officer | 02/28/2021 | 49,138 |
| Estepan Ian Michael | Chief Financial Officer | 03/05/2021 | 29,374 |
| Estepan Ian Michael | Chief Financial Officer | 02/28/2021 | 27,743 |
| INGRAM DOUGLAS S | President & CEO | 12/31/2020 | 6,332,681 |
| Bratica Joseph | Principal Financial Officer | 12/11/2020 | 79,667 |
| Bratica Joseph | Principal Financial Officer | 12/11/2020 | 183,975 |
| Bratica Joseph | Principal Financial Officer | 12/08/2020 | 33,300 |
| Bratica Joseph | Principal Financial Officer | 12/08/2020 | 180,000 |
| Wigzell Hans Lennart Rudolf | Director | 08/10/2020 | 349,200 |
| Wigzell Hans Lennart Rudolf | Director | 08/10/2020 | 1,590,044 |
| Barry Richard | Director | 08/07/2020 | 4,754,972 |
| Bratica Joseph | Principal Financial Officer | 08/03/2020 | 33,300 |
| Bratica Joseph | Principal Financial Officer | 08/03/2020 | 174,375 |
| Mahatme Sandesh | EVP, CFO & CBO | 07/08/2020 | 74,941 |
| Howton David T | EVP, General Counsel | 06/22/2020 | 2,708,440 |
| Howton David T | EVP, General Counsel | 06/22/2020 | 17,962,831 |
| Wigzell Hans Lennart Rudolf | Director | 05/20/2020 | 50,400 |
| Wigzell Hans Lennart Rudolf | Director | 05/20/2020 | 753,210 |
| Barry Richard | Director | 05/15/2020 | 4,237,946 |
| Wigzell Hans Lennart Rudolf | Director | 03/04/2020 | 42,300 |
| Wigzell Hans Lennart Rudolf | Director | 03/04/2020 | 584,450 |
| INGRAM DOUGLAS S | President & CEO | 12/31/2019 | 4,798,352 |
| Cumbo Alexander | EVP, Chief Commercial Officer | 12/13/2019 | 775,232 |
| Cumbo Alexander | EVP, Chief Commercial Officer | 12/13/2019 | 5,271,000 |
| Howton David T | EVP, General Counsel | 12/13/2019 | 1,675,439 |
| Howton David T | EVP, General Counsel | 12/13/2019 | 9,789,000 |
| Mahatme Sandesh | EVP, CFO & CBO | 12/13/2019 | 3,610,443 |
| Mahatme Sandesh | EVP, CFO & CBO | 12/13/2019 | 15,687,500 |
| Howton David T | EVP, General Counsel | 11/22/2019 | 300,084 |
| Howton David T | EVP, General Counsel | 11/22/2019 | 552,667 |
| Howton David T | EVP, General Counsel | 11/22/2019 | 2,625,000 |
| Barry Richard | Director | 09/13/2019 | 289,504 |
| Barry Richard | Director | 09/12/2019 | 147,950 |
| BONNEY MICHAEL W | Director | 09/09/2019 | 173,480 |
| BEHRENS M KATHLEEN | Director | 09/05/2019 | 39,000 |
| BEHRENS M KATHLEEN | Director | 09/06/2019 | 219,950 |
| Mahatme Sandesh | EVP, CFO & CBO | 08/21/2019 | 5,832,698 |
| Mahatme Sandesh | EVP, CFO & CBO | 08/21/2019 | 2,385,000 |
| Barry Richard | Director | 08/20/2019 | 496,592 |
| Mahatme Sandesh | EVP, CFO & CBO | 08/15/2019 | 241,232 |
| Barry Richard | Director | 08/14/2019 | 453,250 |
| Barry Richard | Director | 08/12/2019 | 159,250 |
| INGRAM DOUGLAS S | President & CEO | 08/12/2019 | 2,000,160 |
| O'Neill Gilmore Neil | EVP, R&D & CMO | 05/24/2019 | 552,405 |
| Wigzell Hans Lennart Rudolf | Director | 05/23/2019 | 78,000 |
| Wigzell Hans Lennart Rudolf | Director | 05/23/2019 | 1,200,000 |
| Mahatme Sandesh | EVP, CFO & CBO | 03/28/2019 | 350,462 |
| Howton David T | EVP, General Counsel | 03/28/2019 | 280,322 |
| Cumbo Alexander | EVP, Chief Commercial Officer | 03/28/2019 | 256,942 |
| Mahatme Sandesh | EVP, CFO & CBO | 03/19/2019 | 331,984 |
| Mahatme Sandesh | EVP, CFO & CBO | 03/19/2019 | 332,308 |
| Mahatme Sandesh | EVP, CFO & CBO | 02/07/2019 | 1,550,250 |
| Mahatme Sandesh | EVP, CFO & CBO | 02/07/2019 | 9,425,000 |
| Cumbo Alexander | SVP, Chief Commercial Officer | 02/01/2019 | 169,035 |
| Cumbo Alexander | SVP, Chief Commercial Officer | 02/01/2019 | 2,100,000 |
| Howton David T | SVP, General Counsel | 02/01/2019 | 465,391 |
| Howton David T | SVP, General Counsel | 02/01/2019 | 4,200,000 |
| Mahatme Sandesh | EVP, CFO & CBO | 01/30/2019 | 800,077 |
| Mahatme Sandesh | EVP, CFO & CBO | 01/31/2019 | 505,572 |
| Mahatme Sandesh | EVP, CFO & CBO | 01/30/2019 | 5,694,260 |
| Mahatme Sandesh | EVP, CFO & CBO | 01/31/2019 | 2,771,003 |
| Wigzell Hans Lennart Rudolf | Director | 11/01/2018 | 59,603 |
| Wigzell Hans Lennart Rudolf | Director | 11/01/2018 | 936,714 |
| BEHRENS M KATHLEEN | Director | 10/31/2018 | 39,600 |
| BEHRENS M KATHLEEN | Director | 10/31/2018 | 1,317,100 |
| INGRAM DOUGLAS S | President & CEO | 10/30/2018 | 2,009,872 |
| Mahatme Sandesh | EVP, CFO & CBO | 10/24/2018 | 1,330,389 |
| Mahatme Sandesh | EVP, CFO & CBO | 10/24/2018 | 13,735,116 |
| INGRAM DOUGLAS S | President & CEO | 08/15/2018 | 2,004,208 |
| Cumbo Alexander | SVP, Chief Commercial Officer | 08/08/2018 | 726,120 |
| Howton David T | SVP, General Counsel | 08/08/2018 | 822,936 |
| Mahatme Sandesh | EVP, CFO & CBO | 08/08/2018 | 1,028,791 |
| Howton David T | SVP, General Counsel | 07/16/2018 | 692,691 |
| Howton David T | SVP, General Counsel | 07/16/2018 | 6,823,000 |
| Cumbo Alexander | SVP, Chief Commercial Officer | 07/09/2018 | 465,415 |
| Cumbo Alexander | SVP, Chief Commercial Officer | 07/09/2018 | 4,638,944 |
| Barry Richard | Director | 06/27/2018 | 9,775,500 |
| INGRAM DOUGLAS S | President & CEO | 06/26/2018 | 5,007,291 |
| Ruff Shamim | SVP, Chief Regulatory Affairs | 05/22/2018 | 116,432 |
| Mahatme Sandesh | EVP, CFO & CBO | 05/22/2018 | 180,581 |
| Howton David T | SVP, General Counsel | 05/22/2018 | 139,719 |
| Cumbo Alexander | SVP, Chief Commercial Officer | 05/22/2018 | 128,031 |
| Ruff Shamim | SVP, Chief Regulatory Affairs | 03/15/2018 | 59,778 |
| Ruff Shamim | SVP, Chief Regulatory Affairs | 03/15/2018 | 59,813 |
| Howton David T | SVP, General Counsel | 03/15/2018 | 55,230 |
| Howton David T | SVP, General Counsel | 03/15/2018 | 55,382 |
| Cumbo Alexander | SVP, Chief Commercial Officer | 03/15/2018 | 51,412 |
| Cumbo Alexander | SVP, Chief Commercial Officer | 03/15/2018 | 51,600 |
| Mahatme Sandesh | EVP, CFO & CBO | 03/15/2018 | 59,615 |
| Mahatme Sandesh | EVP, CFO & CBO | 03/15/2018 | 59,625 |
| Wigzell Hans Lennart Rudolf | Director | 11/30/2017 | 49,202 |
| Wigzell Hans Lennart Rudolf | Director | 11/30/2017 | 372,619 |
| INGRAM DOUGLAS S | President & CEO | 11/08/2017 | 1,999,957 |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | 11/06/2017 | 147,600 |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | 11/06/2017 | 550,000 |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | 10/03/2017 | 169,740 |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | 10/03/2017 | 575,000 |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | 08/03/2017 | 109,170 |
| Mahatme Sandesh | EVP, CFO & CBO | 08/03/2017 | 237,280 |
| Howton David T | SVP, General Counsel | 08/03/2017 | 175,839 |
| Kaye Edward M. MD | Director | 08/03/2017 | 632,710 |
| Cumbo Alexander | SVP, Chief Commercial Officer | 08/03/2017 | 120,042 |
| INGRAM DOUGLAS S | President & CEO | 07/27/2017 | 1,999,965 |
| Mahatme Sandesh | EVP, CFO & CBO | 07/20/2017 | 769,107 |
| Mahatme Sandesh | EVP, CFO & CBO | 07/21/2017 | 35,775 |
| Mahatme Sandesh | EVP, CFO & CBO | 07/20/2017 | 2,050,000 |
| Kaye Edward M. MD | Director | 07/20/2017 | 178,005 |
| Kaye Edward M. MD | Director | 07/20/2017 | 410,000 |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | 07/20/2017 | 85,688 |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | 07/21/2017 | 83,133 |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | 07/20/2017 | 262,500 |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | 07/21/2017 | 259,072 |
| Howton David T | SVP, General Counsel | 07/21/2017 | 20,565 |
| Howton David T | SVP, General Counsel | 07/20/2017 | 342,750 |
| Howton David T | SVP, General Counsel | 07/20/2017 | 1,025,000 |
| Cumbo Alexander | SVP, Chief Commercial Officer | 07/20/2017 | 34,275 |
| Cumbo Alexander | SVP, Chief Commercial Officer | 07/20/2017 | 242,638 |
| Kaye Edward M. MD | President & CEO | 04/20/2017 | 141,516 |
| Howton David T | SVP, General Counsel | 03/19/2017 | 4,606 |
| Mahatme Sandesh | EVP, CFO & CBO | 03/19/2017 | 5,181 |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | 03/19/2017 | 5,363 |
| Kaye Edward M. MD | President, CEO & CMO | 01/20/2017 | 145,860 |
| Howton David T | SVP, General Counsel | 11/09/2016 | 23,850 |
| Mahatme Sandesh | Senior Vice President, CFO | 11/09/2016 | 23,850 |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | 11/08/2016 | 26,240 |
| Kaye Edward M. MD | President, CEO & CMO | 11/09/2016 | 24,840 |
| Kaye Edward M. MD | President, CEO & CMO | 10/20/2016 | 213,269 |
| Mahatme Sandesh | Senior Vice President, CFO | 10/17/2016 | 417,000 |
| Mahatme Sandesh | Senior Vice President, CFO | 10/17/2016 | 1,502,502 |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | 09/22/2016 | 101,623 |
| Ruff Shamim | SVP, Regulatory Affairs & Qual | 09/22/2016 | 438,660 |
| Kaye Edward M. MD | President, CEO & CMO | 09/22/2016 | 332,682 |
| Kaye Edward M. MD | President, CEO & CMO | 09/22/2016 | 2,410,740 |
| Howton David T | SVP, General Counsel | 09/22/2016 | 97,300 |
| Howton David T | SVP, General Counsel | 09/22/2016 | 420,000 |
| Aphale Jayant | VP, Technical Operations | 09/19/2016 | 161,700 |
| Aphale Jayant | VP, Technical Operations | 09/19/2016 | 1,750,000 |
| Kaye Edward M. MD | President, CEO & CMO | 09/19/2016 | 168,941 |
| Kaye Edward M. MD | President, CEO & CMO | 09/19/2016 | 1,217,600 |
| Howton David T | SVP, General Counsel | 09/19/2016 | 111,200 |
| Howton David T | SVP, General Counsel | 09/19/2016 | 465,200 |
| Kaye Edward M. MD | SVP Interim CEO & CMO | 09/14/2016 | 736,710 |
| Kaye Edward M. MD | SVP Interim CEO & CMO | 08/31/2016 | 38,766 |
| Mahatme Sandesh | Senior Vice President, CFO | 08/31/2016 | 26,409 |
| Aphale Jayant | SVP, Technical Operations | 08/31/2016 | 19,944 |
| Howton David T | SVP, General Counsel | 08/31/2016 | 23,411 |
| Kaye Edward M. MD | SVP Interim CEO & CMO | 07/20/2016 | 67,402 |
| Kaye Edward M. MD | SVP Interim CEO & CMO | 04/20/2016 | 59,150 |
| BEHRENS M KATHLEEN | Director | 03/16/2016 | 145,433 |
| BEHRENS M KATHLEEN | Director | 03/14/2016 | 1,075,275 |
| Barry Richard | Director | 03/14/2016 | 1,174,185 |
| Price Ben Gil | Director | 03/14/2016 | 75,144 |
| Kaye Edward M. MD | SVP Interim CEO & CMO | 01/20/2016 | 44,660 |
| Kaye Edward M. MD | SVP Interim CEO & CMO | 10/20/2015 | 80,247 |
| Kaye Edward M. MD | SVP Interim CEO & CMO | 07/20/2015 | 100,440 |
| Kaye Edward M. MD | SVP & Chief Medical Officer | 02/27/2015 | 9,452 |
| Christopher Nishan Garabedian | President and CEO | 02/27/2015 | 9,452 |
| CHASE ANTHONY R | Director | 08/12/2014 | 250,446 |
| Aphale Jayant | SVP Technical Operations | 11/12/2013 | 200,134 |
| CHASE ANTHONY R | Director | 11/14/2013 | 139,483 |
| BEHRENS M KATHLEEN | Director | 09/16/2013 | 240,778 |
| HODGMAN JOHN | Director | 09/03/2013 | 97,341 |
| HODGMAN JOHN | Director | 09/03/2013 | 194,316 |
| CHASE ANTHONY R | Director | 08/22/2013 | 114,373 |
| Price Ben Gil | Director | 08/19/2013 | 15,587 |
| Mahatme Sandesh | Senior Vice President, CFO | 08/20/2013 | 155,500 |
| CHASE ANTHONY R | Director | 06/14/2013 | 385,043 |
| CHASE ANTHONY R | Director | 11/28/2012 | 262,689 |
| CHASE ANTHONY R | Director | 11/27/2012 | 31,940 |
| CHASE ANTHONY R | Director | 11/14/2012 | 257,002 |
| CHASE ANTHONY R | Director | 09/07/2012 | 476,959 |
| BEHRENS M KATHLEEN | Director | 09/07/2012 | 257,724 |
| Price Ben Gil | Director | 03/14/2012 | 38,850 |
| Christopher Nishan Garabedian | President and CEO | 12/15/2011 | 173,640 |
| CHASE ANTHONY R | Director | 09/13/2011 | 24,000 |
| Price Ben Gil | Director | 04/06/2011 | 30,000 |
| Christopher Nishan Garabedian | President and CEO | 04/06/2011 | 195,000 |
| BEHRENS M KATHLEEN | Director | 04/06/2011 | 150,000 |
| BOYLE J DAVID II | CEO | 08/27/2010 | 10,645 |
| Price Ben Gil | Director | 08/13/2010 | 7,720 |
| Hudson Leslie | Former CEO | 07/30/2010 | 200,000 |
| Hudson Leslie | Former CEO | 07/30/2010 | 354,113 |
| Hudson Leslie | Former CEO | 07/28/2010 | 200,000 |
| Hudson Leslie | Former CEO | 07/28/2010 | 334,373 |
| Hudson Leslie | Former CEO | 07/26/2010 | 187,170 |
| Hudson Leslie | Former CEO | 07/26/2010 | 245,897 |
| Hudson Leslie | Former CEO | 07/23/2010 | 297,830 |
| Hudson Leslie | Former CEO | 07/23/2010 | 369,720 |
| Hudson Leslie | Former CEO | 07/22/2010 | 385,000 |
| Hudson Leslie | Former CEO | 07/22/2010 | 477,513 |
Load More Insider Transactions
FUNDS WITH A POSITION IN SAREPTA THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,657,000 | 3.42% | New | Other |
| BLACKROCK INC. | 5,482,166 | 0.02% | 2.71% | Other |
| SANDS CAPITAL MANAGEMENT, LLC | 2,151,378 | 1.05% | -13.33% | Growth At A Reasonable Price, Growth |
| GEODE CAPITAL MANAGEMENT, LLC | 1,218,732 | 0.02% | 5.58% | Other |
| ORBIMED ADVISORS LLC | 972,300 | 2.41% | 5.86% | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 928,900 | 0.79% | 23.04% | Event Driven, Value |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 675,000 | 0.21% | -23.73% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 718,878 | 0.13% | -18.7% | Other |
| D. E. SHAW & CO., INC. | 582,247 | 0.08% | -8% | Other |
| BALYASNY ASSET MANAGEMENT LLC | 409,100 (Put) | 0.15% | 7.77% | Event Driven |
| BALYASNY ASSET MANAGEMENT LLC | 368,915 | 0.13% | Exited | Event Driven |
| SENATOR INVESTMENT GROUP LP | 125,000 | 1.46% | New | Event Driven, Value |
| SOROS FUND MANAGEMENT LLC | 101,500 | 0.19% | Exited | Other |
| BRIDGEWATER ASSOCIATES, LP | 57,935 | 0.04% | -41.13% | Other |
| CANDRIAM S.C.A. | 95,144 | 0.08% | New | Other |
| TUDOR INVESTMENT CORP ET AL | 30,412 | 0.08% | -13.72% | Event Driven, Other |
| FISHER ASSET MANAGEMENT, LLC | 12,527 | 0.0011% | -49.58% | Other |
| PLATINUM INVESTMENT MANAGEMENT LTD | 14,248 | 0.07% | New | Growth At A Reasonable Price, Value |
| GOTHAM ASSET MANAGEMENT, LLC | 4,252 | 0.02% | -69.33% | Other |
| D. E. SHAW & CO., INC. | 10,000 (Call) | 0.00143% | No change | Other |
| D. E. SHAW & CO., INC. | 10,000 (Put) | 0.00132% | Exited | Other |
| DUPONT CAPITAL MANAGEMENT CORP | 3,545 | 0.02% | -53.07% | Other |
| CHEYNE CAPITAL MANAGEMENT (UK) LLP | 3,650 | 0.83% | New | Event Driven |
| AQR CAPITAL MANAGEMENT LLC | 2,826 | 0.00083% | 3.48% | Other |
CHANGE IN SHARES OUTSTANDING FOR SAREPTA THERAPEUTICS INC
STOCK BUYBACKS FOR SAREPTA THERAPEUTICS INC
Period of Report: 12/31/2019
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2017
31.04%
10Q
03/31/2017
31.43%
11Q